PMC:7376974 / 13865-15262 JSONTXT 9 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T88 0-64 Sentence denotes Table 1 Antiviral AgNPs and Their Possible Mechanisms of Action
T89 65-136 Sentence denotes virus shape size (nm) active concentration mechanism of action ref
T90 137-199 Sentence denotes HIV-1 spherical 1–10 25 μg/mL interaction with gp120 (11)
T91 200-261 Sentence denotes HIV-1 IIIB – 30–50 440 μg/mL interaction with gp120 (19)
T92 262-387 Sentence denotes HSV-1, HSV-2, and HPIV-3 – 20–50 not available possible interaction directly with the viral envelope or its protein (20)
T93 388-495 Sentence denotes Adenovirus type 3 spherical 5–18 25 μg/mL direct destruction of virus particles and DNA structure (15)
T94 496-657 Sentence denotes H1N1 influenza A virus spherical 5–20 12.5 μg/mL inhibition of respiratory enzymes and electron transport components and interference with DNA function (21)
T95 658-765 Sentence denotes HBV spherical 10–50 5 μM interaction with double-stranded DNA and/or binding with viral particles (16)
T96 766-846 Sentence denotes PPRV spherical 5–30 11.1 μg/mL interaction with virus surface and core (12)
T97 847-937 Sentence denotes Vaccinia virus spherical 25 not available preventing viral entry into host cells (13)
T98 938-1038 Sentence denotes Monkey pox virus (MPV) – 10–80 12.5 μg/mL blocking virus-host cell binding and penetration (22)
T99 1039-1131 Sentence denotes Tacaribe virus (TCRV) – 5–10 25 μg/mL inactivation of virus particles before entry (23)
T100 1132-1243 Sentence denotes Poliovirus spherical 4–9 3.1 ppm preventing viral particles from binding to the receptors of RD cells (24)
T101 1244-1357 Sentence denotes TGEV spherical <20 12.5 μg/mL direct interaction with TGEV surface protein, such as TGEV S glycoprotein (18)
T102 1358-1377 Sentence denotes linear 60000–80000